Plain-English translation of NCT06538038 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is tracking how patients with advanced lung cancer respond to a targeted medication called , which is prescribed as part of routine care. Some patients will receive alone, while others will receive it combined with chemotherapy. The researchers want to understand how well this medication works and how safe it is when used in everyday medical practice, rather than just in controlled clinical trials.
Doctors and researchers need better information about how well newer medications perform when patients receive them in regular hospital and clinic settings, outside of formal research studies. This helps doctors make better decisions about which treatment combination works best for different patients.
You would continue receiving your regular cancer treatment from your doctor while sharing your medical information and treatment outcomes with the research team. Your doctor will decide whether you receive the medication alone or combined with chemotherapy, and will manage your care as usual. The study collects information about how you respond to treatment, any side effects you experience, and your overall health over time.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
United States